Inova Announces Gift to Endow Sheridan Director, Molecular Tumor Board at Inova Schar Cancer Institute

Falls Church, VA —Inova today announced that it has received a $1 million gift from Win Sheridan, co-founder of APEX Systems, to endow the role of the Director of the Molecular Tumor Board at Inova Schar Cancer Institute. In recognition of Sheridan’s generous gift, this position will be renamed to be the Sheridan Director, Molecular…

Read More

How to Tell Your Child About Your Cancer Diagnosis

father embracing son

Practical Strategies for Tough Conversations By Amanda L. Thompson, PhD, and Shari Langer, PsyD Amanda Thompson, PhD, is the Chief of Pediatric Psychology and Director of Pediatric Programs for Life with Cancer, a program of the Inova Schar Cancer Institute. Shari Langer, PsyD, is a pediatric psychologist with Life with Cancer at the Inova L.J.…

Read More

Direct-to-Consumer Genetic Testing for Inherited Cancer Risk

Morgan Turner, MS, CGC, is a Virginia-licensed and nationally board-certified, cancer-specialized genetic counselor at Inova Schar Cancer Institute. She joined Inova in June 2018. Many patients are surprised to learn that the majority of people who are diagnosed with a cancer do not have a genetic (or inherited) cause for their cancer. Indeed, it is…

Read More

Inova Schar Cancer Institute Radiation Oncology Achieves Four-Year Accreditation for Radiation Oncology Services from ASTRO’s APEx – Accreditation Program for Excellence®

Falls Church, VA – Inova is proud to announce that all five radiation oncology departments within the Inova Schar Cancer Institute (ISCI) have been reaccredited by the American Society for Radiation Oncology (ASTRO) for APEx – Accreditation Program for Excellence®. APEx is an accreditation program developed by ASTRO that validates a radiation oncology facility’s excellence…

Read More

Early Study Finds MGC018 Active in Resistant Skin Cancer

Sekwon Jang, MD in medical oncology at Inova Schar Cancer Institute, presented the latest data on the multi-institutional Phase 1 clinical trial for MGC018 at the annual American Society of Clinical Oncology held June 4–8, 2021. What is MGC018? MGC018 is an investigational drug developed by MacroGenics that is being studied for the treatment of…

Read More

Pancreatic Cancer Prevention and Warning Signs

Jennifer L. Gnerlich, MD, FACS, FSSO is a specialty care physician in general surgery and complex general surgical oncology at Inova Schar Cancer Institute. She specializes in upper Gastrointestinal (GI) cancers and carcinomatosis. With the recent deaths of Ruth Bader Ginsburg and Alex Trebek, more people want to know about pancreatic cancer. While not a…

Read More

Free Webinar Oct. 17: Can Diet Help Reduce Cancer Risk?

fruits and vegetables

Online Zoom session: Saturday, Oct. 17 – 9 to 11 a.m. Register at inova.org/food4thought Did you know you can help protect yourself against cancer using food? Inova oncology registered dietitian Lauren Fay says that, aside from not smoking, maintaining a healthy weight throughout life is the best way to protect against cancer. Lauren is leading…

Read More